Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Andrew R Rezvani"'
Autor:
Crystal Mackall, Holden T Maecker, Lekha Mikkilineni, Melody Smith, Saurabh Dahiya, Bita Sahaf, David Miklos, Sally Arai, Surbhi Sidana, Wen-Kai Weng, Dasom Lee, Anmol Goyal, Sushma Bharadwaj, Eric Lau, Mark P Hamilton, Hrishi Srinagesh, Alexandria Jensen, Jayasindhu Mallampet, Sarah Elkordy, Shriya Syal, Sunita Patil, Theresa Latchford, Laura J Johnston, Robert Lowsky, Robert Negrin, Andrew R Rezvani, Judith Shizuru, Everett H Meyer, Parveen Shiraz, Lori Muffly, Matthew J Frank
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Fludarabine in combination with cyclophosphamide (FC) is the standard lymphodepletion regimen for CAR T-cell therapy (CAR T). A national fludarabine shortage in 2022 necessitated the exploration of alternative regimens with many centers em
Externí odkaz:
https://doaj.org/article/4eeab2b9098d4e108c29937f804ef916
Autor:
Benjamin A. Siranosian, Erin F. Brooks, Tessa Andermann, Andrew R. Rezvani, Niaz Banaei, Hua Tang, Ami S. Bhatt
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Here, Siranosian et al. provide evidence for rare transmission of commensal and pathogenic bacteria between the microbiomes of hospitalized adults, with important factors being roommate overlap and exposure to broad-spectrum antibiotics.
Externí odkaz:
https://doaj.org/article/3f658fbd54be4a5e8c5c7f1e23ceebcc
Autor:
Narendranath Epperla, Kwang W. Ahn, Carlos Litovich, Sairah Ahmed, Minoo Battiwalla, Jonathon B. Cohen, Parastoo Dahi, Nosha Farhadfar, Umar Farooq, Cesar O. Freytes, Nilanjan Ghosh, Bradley Haverkos, Alex Herrera, Mark Hertzberg, Gerhard Hildebrandt, David Inwards, Mohamed A. Kharfan-Dabaja, Farhad Khimani, Hillard Lazarus, Aleksandr Lazaryan, Lazaros Lekakis, Hemant Murthy, Sunita Nathan, Taiga Nishihori, Attaphol Pawarode, Tim Prestidge, Praveen Ramakrishnan, Andrew R. Rezvani, Rizwan Romee, Nirav N. Shah, Ana Sureda, Timothy S. Fenske, Mehdi Hamadani
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-11 (2019)
Abstract Background There is a paucity of data on the role of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with angioimmunoblastic T-cell lymphoma (AITL). Using the CIBMTR registry, we report here the outcomes of AITL patients
Externí odkaz:
https://doaj.org/article/19ce45d9a24347588db685661d8cf472
Autor:
Narendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, Madan Jagasia, Alyssa DiGilio, Steven M. Devine, Samantha Jaglowski, Vanessa Kennedy, Andrew R. Rezvani, Sonali M. Smith, Anna Sureda, Timothy S. Fenske, Mohamed A. Kharfan-Dabaja, Phillipe Armand, Mehdi Hamadani
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-12 (2017)
Abstract Background In B cell non-Hodgkin lymphoma (B-NHL), rituximab-containing reduced-intensity conditioning regimens (R-RIC) have been shown to provide favorable outcomes in single-arm studies; however, large multicenter studies comparing R-RIC a
Externí odkaz:
https://doaj.org/article/4327f541cc4a4a5cb2c3d047f951ee3d
Autor:
Michael A Spinner, R. Alejandro Sica, John S Tamaresis, Ying Lu, Cheryl Chang, Robert Lowsky, Matthew J. Frank, Laura J Johnston, David B Miklos, Lori Muffly, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Judith A. Shizuru, Wen-Kai Weng, Michael S. Binkley, Richard T. Hoppe, Ranjana H Advani, Sally Arai
Publikováno v:
Blood.
The treatment landscape of relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL) has evolved significantly over the past decade following the approval of brentuximab vedotin (BV) and the programmed death-1 (PD-1) inhibitors. We evaluated how outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cb81d9ecbc1501e97e41d9231bd1159
https://doi.org/10.1182/blood.2022018827
https://doi.org/10.1182/blood.2022018827
Autor:
Shona Philip, Robert Lowsky, Laura J. Johnston, Sally Arai, Everett H. Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Judith A. Shizuru, Surbhi Sidana, Wen-Kai Weng, Sushma Bharadwaj, Matthew J. Frank, David B. Miklos, Melody Smith, Lori Muffly, Vaibhav Agrawal
Publikováno v:
Blood. 140:4825-4827
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::651b1979ffcecd088d244c89b6554962
https://doi.org/10.1182/blood-2022-168546
https://doi.org/10.1182/blood-2022-168546
Autor:
Shona Philip, Hrishikesh K. Srinagesh, Mark P Hamilton, Cesar Gentille, Alain Mina, Sally Arai, Laura J. Johnston, Robert Lowsky, Everett H Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Judith A Shizuru, Surbhi Sidana, Wen-Kai Weng, Sushma Bharadwaj, Saurabh Dahiya, Lori Muffly, Melody Smith, David B. Miklos, Matthew J Frank
Publikováno v:
Blood. 140:12775-12777
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d84271860d9956aaa25e592a6af89d1d
https://doi.org/10.1182/blood-2022-170877
https://doi.org/10.1182/blood-2022-170877
Autor:
Sushma Bharadwaj, Mark P Hamilton, Bita Sahaf, John Tamaresis, Sunita Patil, Paul J Hanson, Theresa Latchford, Sally Arai, Laura J. Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Judith A Shizuru, Everett H Meyer, Parveen Shiraz, Surbhi Sidana, Melody Smith, Wen-Kai Weng, Lori Muffly, Crystal L. Mackall, Matthew J Frank, David B. Miklos, Saurabh Dahiya
Publikováno v:
Blood. 140:10371-10373
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d223a834312c7a0863804f874d7f7cf
https://doi.org/10.1182/blood-2022-170759
https://doi.org/10.1182/blood-2022-170759
Autor:
Aravind Natarajan, Brayon J. Fremin, Danica T. Schmidtke, Marlene K. Wolfe, Soumaya Zlitni, Katherine E. Graham, Erin F. Brooks, Christopher J. Severyn, Kathleen M. Sakamoto, Norman J. Lacayo, Scott Kuersten, Jeff Koble, Glorianna Caves, Inna Kaplan, Upinder Singh, Prasanna Jagannathan, Andrew R. Rezvani, Ami S. Bhatt, Alexandria B. Boehm
Publikováno v:
bioRxiv
Microbial source tracking (MST) identifies sources of fecal contamination in the environment using fecal host-associated markers. While there are numerous bacterial MST markers, there are few viral markers. Here we design and test novel viral MST mar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff045919a78d04204938aa0d65d34557
https://europepmc.org/articles/PMC9882089/
https://europepmc.org/articles/PMC9882089/
Autor:
Michaela Liedtke, Eric Kuo, David B. Miklos, Ilana R. Yurkiewicz, Matthew J. Frank, Sally Arai, Andrew R. Rezvani, Judith A. Shizuru, Everett Meyer, Laura Johnston, Surbhi Sidana, Sarah Burnash, Hyma T. Vempaty, Wen-Kai Weng, Vandana Sundaram, Connie Chen, Parveen Shiraz, Lori Muffly, Robert S. Negrin, Robert Lowsky, Jay Y. Spiegel
Publikováno v:
Blood Adv
Monitoring of measurable residual disease (MRD) is essential to the management of acute lymphoblastic leukemia (ALL) and is typically performed through repeated bone marrow (BM) assessments. Using a next-generation sequencing (NGS) MRD platform, we p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f14f8da90cff2d3f263b615b8a15cde
https://doi.org/10.1182/bloodadvances.2021004234
https://doi.org/10.1182/bloodadvances.2021004234